Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC. The symptoms of PSC ...

By Tarun Sai Lomte A four-week treatment with oral vancomycin led to clinical remission in PSC-IBD patients, accompanied by ...

Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated ...

Regarding the effect of biliary disease on colitis, there are some open questions following the presented experiments. The study by Bedtke et al does not answer whether it is sclerosing cholangitis ...

Objective Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this ...

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and clinicians. This study aimed to explore the experiences of patients with PSC ...

Researchers have found in a new study that common antibiotic Vancomycin may also be effective in treating individuals with a ...

Reference: Quraishi MN, Cheesbrough J, Rimmer P, et al. Open label vancomycin in primary sclerosing cholangitis-inflammatory ...

文章中，研究者发现，名为万古霉素（vancomycin）的抗生素或能有效治疗患有特定类型炎性肠病（IBD）的患者，这种疾病会在一种无法治愈的称之为原发性硬化性胆管炎（PSC，primary sclerosing ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found. Results published in the Journal of Crohn's and Colitis ...